Keratoconjunctivitis sicca

From Dog
Characterisitc 'dry eye' associated with KCS in dogs[1]
Schirmer tear test for assessment of tear film quantity[2]

Keratoconjunctivitis sicca (KCS; dry eye) is a common eye disease of dogs.

This disease is characterized by inflammation of the lacrimal glands, resulting in reduced or absent tear formation and secondary bacterial conjunctivitis.

The disease results in a significant reduction in goblet cell activity and consequent tear formation, specifically sialoglycoproteins, leading to reduced mucin content of tears[3].

Causes of KCS include (in order of importance):

In rare cases associated with brachycephalic breeds, corneal squamous cell carcinoma have been reported as a sequela to this disease[23].

The lacrimotoxic effect of sulphasalazine is permanent in many cases and it is recommended that dogs on this drug should be monitored for tear secretion at regular intervals.

Clinically affected eyes have a mucoid or mucopurulent discharge, with conjunctivitis and a dull cornea that may be ulcerated, pigmented or vascularized.

A Schirmer's tear test is usually diagnostic, with KCS eyes having < 10 mm/min of wetting. Severely affected dogs often have an STT result of 0 mm/min. Bear in mind that the mean STT in dogs decreases by 0.4 mm for every year of age[24].

A definitive diagnosis is usually based on histological analysis often reveals conjunctival hyperemia, mucopurulent ocular discharge, predominant lymphoplasmacytic infiltration, and acantholysis and keratinization of the ocular surface.

A differential diagnosis would include proliferative conjunctivitis and Meibomian carcinoma.

Medical treatment is the primary method of control of this disease with systemic pilocarpine (1 - 2% eye drops), broad-spectrum topical antimicrobials and 0.2% cyclosporine, 0.02% tacrolimus[25] or 1% pimecrolimus[26].

Both cyclosporine and tacrolimus are effective in increasing the STT in dogs naïve to lacrimostimulants but tacrolimus should only be used as a second-line agent for short-term and intermittent use due to its carcinogenic properties[27].

In neurogenic KCS, pilocarpine is extended for 3 - 4 months[28].

Surgical treatments are indicated in severe cases, or those unresponsive to medical intervention, and include ventral punctal occlusion[29], tarsorrhaphy, conjunctival flaps, contact lenses, superficial keratectomy, keratoprosthesis[30], intraocular prosthesis[31], as well as parotid duct transposition[32] and submandibular gland transplantation[33].

Prognosis is variable, depending on cause, but most dogs have a good response to medical treatment.

References

  1. Health Pics
  2. Enpen Vet
  3. Corfield AP et al (2005) Identification of 9-O-acetyl-N-acetylneuraminic acid in normal canine pre-ocular tear film secreted mucins and its depletion in Keratoconjunctivitis sicca. Glycoconj J 22(7-9):409-416
  4. Balicki I et al (2008) Studies on keratoconjunctivitis sicca incidence in crossbred dogs. Pol J Vet Sci 11(4):353-358
  5. Westermeyer HD et al (2009) Breed predisposition to congenital alacrima in dogs. Vet Ophthalmol 12(1):1-5
  6. Sanchez RF et al (2007) Canine keratoconjunctivitis sicca: disease trends in a review of 229 cases. J Small Anim Pract 48(4):211-217
  7. Hartley C et al (2012) Congenital keratoconjunctivitis sicca and ichthyosiform dermatosis in Cavalier King Charles spaniel dogs. Part II: candidate gene study. Vet Ophthalmol 15(5):327-332
  8. Forman OP et al (2012) Parallel mapping and simultaneous sequencing reveals deletions in BCAN and FAM83H associated with discrete inherited disorders in a domestic dog breed. PLoS Genet 8(1):e1002462
  9. Williams DL et al (2007) Reduced tear production in three canine endocrinopathies. J Small Anim Pract 48(5):252-256
  10. Nagayasu A et al (2008) Morphological analysis of corneal opacity in Shiba dog with GM1 gangliosidosis. J Vet Med Sci 70(9):881-886
  11. Ledbetter EC et al (2006) Corneal ulceration associated with naturally occurring canine herpesvirus-1 infection in two adult dogs. J Am Vet Med Assoc 229(3):376-384
  12. de Almeida DE et al (2009) Conjunctival effects of canine distemper virus-induced keratoconjunctivitis sicca. Vet Ophthalmol 12(4):211-215
  13. Swinger RL et al (2009) Keratoconjunctivitis associated with Toxoplasma gondii in a dog. Vet Ophthalmol 12(1):56-60
  14. Naranjo C et al (2005) Characterization of lacrimal gland lesions and possible pathogenic mechanisms of keratoconjunctivitis sicca in dogs with leishmaniosis. Vet Parasitol 133(1):37-47
  15. Barnes LD et al (2010) Surgical management of orbital nodular granulomatous episcleritis in a dog. Vet Ophthalmol 13(4):251-258
  16. Williams DL (2008) Immunopathogenesis of keratoconjunctivitis sicca in the dog. Vet Clin North Am Small Anim Pract 38(2):251-268
  17. Klauss G et al (2007) Keratoconjunctivitis sicca associated with administration of etodolac in dogs: 211 cases (1992-2002). J Am Vet Med Assoc 230(4):541-547
  18. Sansom J et al (1985) Keratoconjunctivitis sicca in the dog associated with the administration of salicylazosulphapyridine (sulphasalazine). Vet Rec 116(15):391-393
  19. Trepanier LA (2004) Idiosyncratic toxicity associated with potentiated sulfonamides in the dog. J Vet Pharmacol Ther 27(3):129-138
  20. Ruehlmann D et al (2001) Treatment of partial seizures and seizure-like activity with felbamate in six dogs. J Small Anim Pract 42(8):403-408
  21. Ofri R et al (2007) Canine meibometry: establishing baseline values for meibomian gland secretions in dogs. Vet J 174(3):536-540
  22. Saito A et al (2004) Morphologic changes of the anterior corneal epithelium caused by third eyelid removal in dogs. Vet Ophthalmol 7(2):113-119
  23. Dreyfus J et al (2011) Superficial corneal squamous cell carcinoma occurring in dogs with chronic keratitis. Vet Ophthalmol 14(3):161-168
  24. Hartley C et al (2006) Effect of age, gender, weight, and time of day on tear production in normal dogs. Vet Ophthalmol 9(1):53-57
  25. Berdoulay A et al (2005) Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca. Vet Ophthalmol 8(4):225-232
  26. Ofri R et al (2009) Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: a comparison with cyclosporine A. Vet J 179(1):70-77
  27. Hendrix DV et al (2011) An investigation comparing the efficacy of topical ocular application of tacrolimus and cyclosporine in dogs. Vet Med Int 2011:487592
  28. Matheis FL et al (2012) Canine neurogenic Keratoconjunctivitis sicca: 11 cases (2006-2010). Vet Ophthalmol 15(4):288-290
  29. Williams DL (2002) Use of punctal occlusion in the treatment of canine keratoconjunctivitis sicca. J Small Anim Pract 43(11):478-481
  30. Isard PF et al (2010) Keratoprosthesis with retrocorneal fixation: preliminary results in dogs with corneal blindness. Vet Ophthalmol 13(5):279-288
  31. Lin CT et al (2007) Surgical outcome and ocular complications of evisceration and intraocular prosthesis implantation in dogs with end stage glaucoma: a review of 20 cases. J Vet Med Sci 69(8):847-850
  32. Barnett KC & Sansom J (1987) Diagnosis and treatment of keratoconjunctivitis sicca in the dog. Vet Rec 120(14):340-345
  33. Chen WL et al (2008) Transplantation of a reverse facial artery pedicled submandibular gland in a dog. Int J Oral Maxillofac Surg 37(11):1054-1058